Evaluation of the impact of treatment delays and dose reductions on tumor response in human ovarian cancer xenograft models

被引：0
|
作者：
Hong, Jing [1 ]
Saucier, Jenifer M. [2 ]
Gaikwad, Anjah [2 ]
Brown, Jubilee [2 ]
Smith, Judith A. [1 ,2 ,3 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Pharm, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[3] Univ Texas Hlth Sci Ctr Houston, Houston Med Sch, Houston, TX USA
来源：
REPRODUCTIVE SCIENCES | 2008年 / 15卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
860
引用
收藏
页码：302A / 302A
页数：1
相关论文
共 50 条
  • [41] Human papilloma virus status impact upon the full tumor response for treatment anal cancer
    Chernykh, M.
    Gladilina, I.
    Kozlov, O.
    Trigolosov, A.
    Nechushkin, M.
    Kravchenko, D.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S337 - S337
  • [42] Preclinical evaluation of huC242-DM4 in tumor xenograft models of canag-positive human gastric cancer.
    Carrigan, Christina N.
    Mayo, Michele F.
    Xie, Hongsheng
    Lambert, John M.
    Chari, Chari V. J.
    Payne, Gillian
    Lutz, Robert J.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3449S - 3449S
  • [43] Circulating tumor cells as a biomarker of response to treatment in patient derived xenograft mouse models of pancreatic adenocarcinoma
    Torphy, Robert J.
    Tignanelli, Christopher J.
    Moffitt, Richard A.
    Soper, Steven A.
    Yeh, Jen Jen
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2013, 217 (03) : S30 - S30
  • [44] Developing patient-derived organoids and tumor xenograft model for ovarian cancer for preclinical therapeutic evaluation.
    Kim, Jihee
    Seo, Ji Hyeong
    Kim, Yun-Hee
    Woo, YoHan
    Lee, Yeon Jee
    Kim, Yena
    Choi, Wonyoung
    Kim, Young Ju
    Yoo, Chong Woo
    Park, Sang Yoon
    Lim, Myong Cheol
    Kong, Sun-Young
    CANCER RESEARCH, 2022, 82 (12)
  • [45] In vivo evaluation of Bevacizumab as a single agent or in combination with standard agents in a panel of human tumor xenograft models
    Marty, Jennifer
    Sepulveda, Mario
    Lowell, Wesley
    Gomez, Lionel
    Kelley, Scott
    Koehler, Gretchann
    Wick, Miachael J.
    Takimoto, Chris
    CANCER RESEARCH, 2006, 66 (08)
  • [46] Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapies
    Depreeuw, Jeroen
    Hermans, Els
    Schrauwen, Stefanie
    Annibali, Daniela
    Coenegrachts, Lieve
    Thomas, Debby
    Luyckx, Mathieu
    Gutierrez-Roelens, Ilse
    Debruyne, David
    Konings, Katrien
    Moerman, Philippe
    Vergote, Ignace
    Lambrechts, Diether
    Amant, Frederic
    GYNECOLOGIC ONCOLOGY, 2015, 139 (01) : 118 - 126
  • [47] Retrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients
    Liutkauskiene, Sigita
    Janciauskiene, Rasa
    Jureniene, Kristina
    Grizas, Saulius
    Malonyte, Rasa
    Juozaityte, Elona
    BMC CANCER, 2015, 15
  • [48] Retrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients
    Sigita Liutkauskiene
    Rasa Janciauskiene
    Kristina Jureniene
    Saulius Grizas
    Rasa Malonyte
    Elona Juozaityte
    BMC Cancer, 15
  • [49] Functional evaluation of homologous recombination to predict treatment response in ovarian cancer
    Geissler, Franziska
    Coelho, Ricardo
    Tibor, Zwimpfer
    Fedier, Andre
    Jacob, Francis
    Heinzelmann-Schwarz, Viola
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 129 : 37 - 38
  • [50] In vivo evaluation of combination treatment with gemcitabine (dFdC) and tetrahydrouridine (THU) in xenograft models of pancreatic cancer
    Eiseman, Julie
    Bai, Lihua
    Liggett, Dana
    Egorin, Merrill
    Covey, Joseph
    Beumer, Jan
    CANCER RESEARCH, 2009, 69
12345